Hiroko Inada
-
- Childhood Cancer Survivors' Quality of Life 18
- Neurology top 10%
- Neuroblastoma Research and Treatments 5
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation 6
- Acute Myeloid Leukemia Research 4
- Speech and Hearing top 5%
-
- Acute Lymphoblastic Leukemia research 17
-
- Lymphoma Diagnosis and Treatment 7
-
- Family Support in Illness 6
-
- RNA Interference and Gene Delivery 3
- Co-authors
- Keizo HoribeJun OkamuraShuichi OzonoHideki IzumiAkira NakagawaraYuanyuan LiMasanori NishiYasushi Ishida
- Journals
- Pediatric Blood & Cancer (7 papers)International Journal of Hematology (6 papers)Japanese Journal of Clinical Oncology (2 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Hiroko Inada
49 papers receiving 812 citations
Peers
Comparison fields: 5 of 77
- Pediatrics, Perinatology and Child Health 321
- Neurology 171
- Hematology 111
- Speech and Hearing 56
- Public Health, Environmental and Occupational Health 236
Countries citing papers authored by Hiroko Inada
This map shows the geographic impact of Hiroko Inada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Inada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Inada more than expected).
Fields of papers citing papers by Hiroko Inada
This network shows the impact of papers produced by Hiroko Inada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Inada. The network helps show where Hiroko Inada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroko Inada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 15 | |
| 2 | 2015 | 5 | |
| 3 | 2014 | 35 | |
| 4 | 2013 | 21 | |
| 5 | 2012 | 16 | |
| 6 | 2011 | 22 | |
| 7 | 2010 | 36 | |
| 8 | 2010 | 44 | |
| 9 | 2010 | 75 | |
| 10 | 2009 | 11 | |
| 11 | 2008 | 24 | |
| 12 | 2006 | 8 | |
| 13 | 2005 | 8 | |
| 14 | 2005 | 10 | |
| 15 | 2001 | 3 | |
| 16 | 1999 | 6 | |
| 17 | 1996 | 33 | |
| 18 | 1995 | 1 | |
| 19 | 1994 | 1 | |
| 20 | 1992 | 1 |
About Hiroko Inada
Hiroko Inada is a scholar working on Hematology, Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Genetics, having authored 49 papers that have together received 817 indexed citations. Recurring topics across this work include Childhood Cancer Survivors' Quality of Life (18 papers), Acute Lymphoblastic Leukemia research (17 papers), Lymphoma Diagnosis and Treatment (7 papers), Family Support in Illness (6 papers), Hematopoietic Stem Cell Transplantation (6 papers), Neuroblastoma Research and Treatments (5 papers), Acute Myeloid Leukemia Research (4 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (321 citations), Neurology (171 citations), Hematology (111 citations), Speech and Hearing (56 citations) and Public Health, Environmental and Occupational Health (236 citations). Hiroko Inada has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Keizo Horibe, Jun Okamura, Shuichi Ozono, Hideki Izumi, Akira Nakagawara, Yuanyuan Li, Masanori Nishi, Yasushi Ishida, Kiyoko Kamibeppu and Keiko Asami. Their work appears in journals such as Pediatric Blood & Cancer, International Journal of Hematology, Japanese Journal of Clinical Oncology, Blood and Journal of Pediatric Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.